New legislation would suspend the Affordable Care Act’s medical device tax for 5 years; teenagers are now more likely to vape or use marijuana than smoke cigarettes; California women can access birth control at a pharmacist without a doctor’s prescription, but are unlikely to do so.
The medical device tax in the Affordable Care Act (ACA) has been a controversial provision that has already been delayed. Now, new legislation from Republicans in the House of Representatives could delay the implementation of the tax yet again, reported Forbes. The bill would suspend the 2.3% tax on medical devices sales for another 5 years. Republicans tried to pass a permanent repeal of the tax as part of their attempts to repeal and replace the ACA. Repealing the tax is expected to cost the US Treasury $20 billion over a decade.Cigarette smoking has dropped sharply among teenagers in the United States, and instead, vaping and marijuana use are more common. According to The New York Times, a survey found less than 10% of high school seniors reported smoking cigarettes in the last 30 days compared with 22.9% who used marijuana and 16.6% who had vaped. While the researchers were impressed with the reduction in cigarette smoking, they remain concerned that the health effects of vaping are still unknown. In addition, a very small percentage of respondents believed there was a “great risk” from smoking marijuana occasionally.Although California allows women to get birth control pills at a pharmacy without a prescription from their doctor, few women actually do. Only 11% of pharmacies in the state are dispensing birth control pills, which means women are having a hard time finding a place where they can get their contraceptives, according to Los Angeles Times. Some pharmacists are reluctant to offer birth control bills because of liability, lack of staffing, and reimbursement issues. In order to provide birth control to women, the pharmacist has to administer a questionnaire about health issues.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More